GKN Aerospace and Rolls Royce Form Joint Venture

GKN Aerospace announced today that it has established a joint venture company with Rolls-Royce to carry out research and development into the use of composite materials in aero engine fan blades.

As part of its continuous drive to bring innovative products to market, Rolls-Royce is researching key technologies and alternative materials to further enhance the efficiency and environmental performance of its products.

Funding for the research and development is expected to be approximately ?11 million.

Rolls-Royce will fund and own 51 per cent of the venture, with GKN Aerospace responsible for 49 per cent.

The joint venture activities will build upon the development of composite blade applications undertaken during the EU-funded VITAL programme, and will combine the expertise of Rolls-Royce advanced engine technologies with GKN Aerospace's composite research and automated manufacturing technologies.

Rolls-Royce Director - Research and Technology Ric Parker said: "Rolls-Royce has been working closely with GKN Aerospace on the latest carbon-composite technologies for some time and we look forward to building on this relationship with the formation of the joint venture. The composite technology research that this organisation will undertake is aimed at delivering light-weight and low-cost fan blades for engines for the next generation of airframe applications."

GKN Aerospace Chief Executive Officer Marcus Bryson said: "We have long been a pioneer and driving force in the application of lightweight, high-performance composites to the airframe and it is one of our strategic goals to bring the benefits of composite materials to propulsion systems.

This JV represents a critical step towards achieving that goal. Through our partnership with Rolls-Royce, we will achieve a genuine advance in propulsion system technology that will move us towards a lighter, more environmentally efficient aero-engine."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.